Not applicableLooking for participantsNCT07124000What this trial is testingDESTINY-PANTUMOUR04Who this might be right forAdenocarcinoma (NOS)Anal CancerBladder Cancer+24 more AstraZeneca 100
Early research (Phase 1)Ended earlyNCT06580938What this trial is testingLearn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With CancerWho this might be right forNon Small Cell Lung CancerBladder CancerRenal Cell Carcinoma+3 more Pfizer 4
Early research (Phase 1)Study completedNCT02009449What this trial is testingPegilodecakin (LY3500518) in Participants With Advanced Solid TumorsWho this might be right forMelanomaProstate CancerOvarian Cancer+6 more Eli Lilly and Company 353
Testing effectiveness (Phase 2)UnknownNCT05013099What this trial is testingStudy of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic MalignanciesWho this might be right forMelanomaMerkel Cell Carcinoma, UnspecifiedRenal Cell Carcinoma+1 more ImaginAb, Inc. 70
Testing effectiveness (Phase 2)Study completedNCT03693612What this trial is testingGSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid TumorsWho this might be right forNeoplasms GlaxoSmithKline 26
Not applicableWithdrawnNCT04941365What this trial is testingQuantifying Systemic Immunosuppression to Personalize Cancer TherapyWho this might be right forMetastatic MelanomaMetastatic Breast CancerAdvanced Renal Cell Carcinoma+3 more Institut du Cancer de Montpellier - Val d'Aurelle
Testing effectiveness (Phase 2)Looking for participantsNCT06580002What this trial is testingRepurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialWho this might be right forBreast CancerSarcomaGastric Cancer+19 more University of California, Irvine 75
Testing effectiveness (Phase 2)WithdrawnNCT02763761What this trial is testingAn Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or OpdivoWho this might be right forRenal Cell CarcinomaMelanomaLung Cancer Bristol-Myers Squibb
Testing effectiveness (Phase 2)UnknownNCT04631731What this trial is testingRisk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin ToxicityWho this might be right forLung Cancer, Nonsmall CellRenal Cell CarcinomaMelanoma+4 more Western Sydney Local Health District 200
Very early researchStudy completedNCT00276835What this trial is testingGenistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney CancerWho this might be right forKidney CancerMelanoma (Skin) Northwestern University 15
Testing effectiveness (Phase 2)Ended earlyNCT03829501What this trial is testingA Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced MalignanciesWho this might be right forSquamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more Kymab Limited 222
Early research (Phase 1)Study completedNCT05858736What this trial is testingSafety, PK and Efficacy of AI-061 in Advanced Solid TumorsWho this might be right forMelanomaNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+14 more OncoC4, Inc. 18
Early research (Phase 1)Study completedNCT03894618What this trial is testingSL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or LymphomasWho this might be right forSquamous Cell Carcinoma of the Head and NeckMelanomaNon Small Cell Lung Cancer+10 more Shattuck Labs, Inc. 49
Testing effectiveness (Phase 2)Looking for participantsNCT07223424What this trial is testingPatient Preference for Subcutaneous vs. Intravenous Immune TherapyWho this might be right forRenal Cell CarcinomaNon Small Cell Lung CancerMelanoma+9 more Diwakar Davar 880
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060What this trial is testingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more National Cancer Institute (NCI) 6,452
Testing effectiveness (Phase 2)Study completedNCT03207347What this trial is testingA Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)Who this might be right forMesotheliomaUveal MelanomaRenal Cell Carcinoma+1 more University of Florida 37
Early research (Phase 1)Ended earlyNCT06336148What this trial is testingA Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor Actym Therapeutics, Inc. 10
Not applicableLooking for participantsNCT03702309What this trial is testingLiquid Biopsy Evaluation and Repository Development at Princess MargaretWho this might be right forCancerBreast CancerLung Cancer+15 more University Health Network, Toronto 2,500
Early research (Phase 1)Ended earlyNCT04301011What this trial is testingStudy of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid TumorsWho this might be right forSolid TumorMicrosatellite Stable Colorectal CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+6 more Turnstone Biologics, Corp. 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT05879822What this trial is testingEvaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor NaiveWho this might be right forAdvanced Solid Tumor Incyte Corporation 73